Specialty Utilization Disparities Among Hidradenitis Suppurativa Patients in a Retrospective Analysis of the National Ambulatory Medical Care Survey 2006-2016

Udechukwu, N. S., & Fleischer, A. B., Jr (2017). Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United States. Journal of the National Medical Association, 109(1), 44–48. https://doi.org/10.1016/j.jnma.2016.09.002

Khalsa, A., Liu, G., & Kirby, J. S. (2015). Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology, 73(4), 609–614. https://doi.org/10.1016/j.jaad.2015.06.053

Robinson, I., Lee, L., & Cotton, C. (2022). The Impact of Racial Differences on Treatment Strategies in Hidradenitis Suppurativa: A Retrospective Review. Journal of drugs in dermatology : JDD, 21(3), 270–275. https://doi.org/10.36849/JDD.6446

Wehner, M. R., Micheletti, R., Noe, M. H., Linos, E., Margolis, D. J., & Naik, H. B. (2020). Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. Journal of the American Academy of Dermatology, 82(5), 1239–1241. https://doi.org/10.1016/j.jaad.2019.12.030

Davis, S. A., Lin, H. C., Balkrishnan, R., & Feldman, S. R. (2015). Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases. Skin appendage disorders, 1(2), 65–73. https://doi.org/10.1159/000431037